This funding announcement focuses on interventions delivered in settings where delirium patients are typically treated, such as ICUs, emergency departments, long-term care, or a combination of clinical/community/home-based settings. Studies in hospital and long-term care facilities are highly encouraged. Multisite studies (e.g., across multiple sites within a health system, preferably in diverse geographies, across multiple healthcare systems, or across multiple communities) are recommended in order to support widespread implementation of effective interventions. A study with interventions exclusively delivered in palliative or institutional end-of-life care settings will be considered nonresponsive.
What intervention settings are allowable under this funding announcement?
Have more questions? Submit a request